5 unknown. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow terevalefim: new trials by email Literature Review of terevalefim trials Research Report on terevalefim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects ANG-3777 - Hemodialysis | Phase 1 | Unknown | Angion Biomedica Corp | 16 | 2021-07-01 | 2021-07-15 |
| Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval ANG-3777 (Therapeutic Dose), ANG-3777 (Supra-therapeutic Dose), Placebo - Healthy Volunteer | Phase 1 | Unknown | Angion Biomedica Corp | 48 | 2021-06-01 | 2021-06-01 |
| Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia Standard of Care (SOC) + ANG-3777, Standard Of Care (SOC) + Placebo - COVID-19, Pneumonia | Phase 2 | Unknown | Angion Biomedica Corp | 100 | 2020-07-31 | 2021-04-15 |
| Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass ANG-3777, Placebo - Acute Kidney Injury | Phase 2 | Unknown | Angion Biomedica Corp | 275 | 2017-02-24 | 2021-07-15 |
| Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney ANG-3777, Placebo - Delayed Graft Function | Phase 3 | Unknown | Angion Biomedica Corp | 253 | 2016-03-01 | 2021-06-03 |
Acute Kidney Injury (2) · Acute Lung Injury (1) · COVID-19 (1) · Delayed Graft Function (1) · Pneumonia (1) · Respiratory Distress Syndrome (1) · Respiratory Insufficiency (1)
United States (4) · Brazil (2) · Canada (1) · Georgia (1)
John Neylan, MD (3) · Daniel K. Ries, MD (1) · Jeffrey Levy, MD, PhD (1)